Showing results (231-240 of 610) with videos related to
Sort By:
Pageof 61
The American Journal of Physiology|December 31, 1997
Molecular analysis of blood vessel formation and diseaseP Carmeliet, D CollenSeminars in Thrombosis and Hemostasis|January 1, 1996
Gene manipulation and transfer of the plasminogen and coagulation system in miceP Carmeliet, D CollenThrombosis and Haemostasis|May 1, 1996
Comparative effects of staphylokinase and alteplase in rabbit bleeding time modelsS Vanderschueren, D CollenThrombosis and Haemostasis|October 1, 1981
Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitorC Korninger, D CollenThe International Journal of Biochemistry & Cell Biology|August 8, 1998
Tissue factorP Carmeliet, D CollenThe Journal of Biological Chemistry|November 1, 1996
Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrinD V Sakharov, H R Lijnen, D C RijkenThe Journal of Biological Chemistry|April 14, 1995
Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric moleculesV Novokhatny, L Medved, H R Lijnen, et al.Biochemical and Biophysical Research Communications|November 22, 2008
Deficiency of vascular endothelial growth factor-D does not affect murine adipose tissue developmentH R Lijnen, L Frederix, B Van Hoef, et al.Thrombosis Research|December 1, 1988
Characterization of a chimaeric plasminogen activator obtained by insertion of the second kringle structure of tissue-type plasminogen activator (amino acids 173 through 262) between residues Asp130 and Ser139 of urokinase-type plasminogen activatorH R Lijnen, L Piérard, M E Reff, et al.Advances in Experimental Medicine and Biology|January 1, 1990
New developments in thrombolytic therapyD Collen, H K GoldPageof 61